Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of These 10 Stocks Are Making Big Moves. Viking Therapeutics jumped by 9.74 ...

Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of ...

A systematic review of almost 50 randomized clinical trials brings some clarity to concerns about antidepressant withdrawal ...

NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...

BEACON and Open-Label Extension Study Design and Data Summary: ...

Rates of mortality, chronic conditions, obesity, and mental health have worsened and compare poorly with high-income peer countries.

In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer ("mCRPC"),the six-month radiographic progres ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases. This rise ...

Researchers have provided robust scientific evidence that ailments like depression, high blood pressure, diabetes mellitus, ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD - - Broadens global development program for vereki ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...